Using Rhodamine-RCA to Identify Cancer Blood Vessels
Author Information
Author(s): Hunter Finie, Xie Jianwu, Trimble Cameron, Bur Monica, Li King CP
Primary Institution: Molecular Imaging Laboratory, Clinical Center, National Institutes of Health, Bethesda, MD, USA
Hypothesis
The phenotypes of in vivo labeled endothelial cells and IHC stained endothelial cells are distinct.
Conclusion
In vivo Rhodamine RCA angiogenic vessel labeling effectively guides the isolation of functional endothelial cells, resulting in high-quality RNA for genomic expression analysis.
Supporting Evidence
- Rhodamine-RCA lectin successfully labeled functional tumor vessels.
- Total RNA concentration increased significantly after laser capture microdissection.
- High-quality RNA was retrieved from endothelial cells with minimal contamination.
Takeaway
The study shows a new way to mark and study blood vessels in tumors, helping scientists understand how to target cancer treatments better.
Methodology
Female C3H mice with SCCVII tumors were injected with Rhodamine-RCA, and laser capture microdissection was used to isolate endothelial cells for RNA analysis.
Limitations
The study's in vivo labeling technique may be limited by the timing of euthanasia after lectin administration and potential toxicity of the lectin.
Participant Demographics
Female C3H mice, aged 6-9 weeks.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website